CIK: 0001703031 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value ($000): $1,244,288 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 10,473,913 | $247,708 | 19.9% | $10.64 | +90.8% | ORDINARY SHARES | N62509109 |
| NUVL | NUVALENT INC | 2,697,267 | $202,538 | 16.3% | $28.96 | +174.8% | COM | 670703107 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,992,028 | $89,761 | 7.2% | $21.73 | 0.0% | COM | 252828108 |
| IRON | DISC MEDICINE INC | 1,317,213 | $82,010 | 6.6% | $22.28 | +191.0% | COM | 254604101 |
| KYTX | KYVERNA THERAPEUTICS INC | 3,163,868 | $78,590 | 6.3% | $27.84 | 0.0% | COM | 501976104 |
| PHVS | PHARVARIS N V | 3,303,381 | $76,341 | 6.1% | $23.89 | +11.2% | COM | N69605108 |
| SVRA | SAVARA INC | 14,565,457 | $72,536 | 5.8% | $1.94 | +149.6% | COM | 805111101 |
| ANNX | ANNEXON INC | 8,703,268 | $62,402 | 5.0% | $11.24 | -53.8% | COM | 03589W102 |
| SLDB | SOLID BIOSCIENCES INC | 4,034,582 | $53,741 | 4.3% | $7.18 | +30.3% | COM NEW | 83422E204 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 196,995 | $52,606 | 4.2% | $174.99 | +34.7% | COM | 558868105 |
| — | MERSANA THERAPEUTICS INC | 8,663,673 | $38,813 | 3.1% | $12.65 | — | COM | 59045L106 |
| CABA | CABALETTA BIO INC | 1,617,364 | $27,592 | 2.2% | $10.85 | +97.7% | COM | 12674W109 |
| — | X4 PHARMACEUTICALS INC | 16,915,784 | $23,513 | 1.9% | $2.22 | — | COM | 98420X103 |
| TNGX | TANGO THERAPEUTICS INC | 2,892,663 | $22,968 | 1.8% | $10.01 | +7.1% | COM | 87583X109 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 2,011,687 | $19,936 | 1.6% | $26.87 | -72.2% | COM | 03969K108 |
| NRIX | NURIX THERAPEUTICS INC | 1,132,397 | $16,646 | 1.3% | $21.10 | -49.0% | COM | 67080M103 |
| SYRS | SYROS PHARMACEUTICALS INC | 2,749,808 | $14,711 | 1.2% | $5.62 | +23.0% | COM NEW | 87184Q206 |
| — | MARINUS PHARMACEUTICALS INC | 1,393,380 | $12,596 | 1.0% | $15.48 | — | COM NEW | 56854Q200 |
| AVIR | ATEA PHARMACEUTICALS INC | 2,485,638 | $10,042 | 0.8% | $32.23 | -87.9% | COM | 04683R106 |
| CCCC | C4 THERAPEUTICS INC | 1,142,210 | $9,332 | 0.7% | $29.00 | -73.3% | COM STK | 12529R107 |
| RPID | RAPID MICRO BIOSYSTEMS INC | 8,434,560 | $8,182 | 0.7% | $20.66 | -95.3% | CLASS A COM | 75340L104 |
| IVVD | INVIVYD INC | 1,799,595 | $7,990 | 0.6% | $37.11 | -88.9% | COM | 00534A102 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 2,000,000 | $5,880 | 0.5% | $10.83 | -73.8% | COM | 63909J108 |
| ACRS | ACLARIS THERAPEUTICS INC | 3,000,000 | $3,720 | 0.3% | $12.42 | -90.4% | COM | 00461U105 |
| XLO | XILIO THERAPEUTICS INC | 2,805,413 | $3,030 | 0.2% | $17.03 | -96.0% | COM | 98422T100 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 100,000 | $1,104 | 0.1% | $0.00 | — | *W EXP 99/99/999 | N62509117 |